triple agonist retatrutide Mazdutide vs retatrutide: dual meets agonist in the next-gen weight loss showdown Who Makes Retatrutide? Company Behind

Misuse for Weight Loss: Despite FDA approval only for diabetes, many non-diabetic individuals are using Ozempic for weight loss, risking side effects without medical oversight

A Joint Advisory on nutritional support for GLP-1 therapy for obesity was issued by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society in May of 2025

In a separate study, subjects exhibited as much as a 26.1% reduction in total body fat mass post treatment

Her approach combines leadership with personal involvement, possibly impacting Kims weight loss journey

Please refer to the FDA-approved Kybella label for a full list of the side effects associated with this drug